UK Markets close in 6 hrs 45 mins
  • FTSE 100

    7,240.11
    +35.56 (+0.49%)
     
  • FTSE 250

    22,939.73
    +8.07 (+0.04%)
     
  • AIM

    1,233.98
    -0.21 (-0.02%)
     
  • GBP/EUR

    1.1829
    +0.0029 (+0.24%)
     
  • GBP/USD

    1.3780
    +0.0021 (+0.1516%)
     
  • BTC-GBP

    45,610.04
    +1,450.72 (+3.29%)
     
  • CMC Crypto 200

    1,453.34
    -49.70 (-3.31%)
     
  • S&P 500

    4,544.90
    -4.88 (-0.11%)
     
  • DOW

    35,677.02
    +73.92 (+0.21%)
     
  • GOLD FUTURES

    1,801.50
    +5.20 (+0.29%)
     
  • NIKKEI 225

    28,600.41
    -204.44 (-0.71%)
     
  • HANG SENG

    26,132.03
    +5.10 (+0.02%)
     
  • DAX

    15,566.35
    +23.37 (+0.15%)
     
  • CAC 40

    6,728.14
    -5.55 (-0.08%)
     

CytomX Therapeutics, inc (CTMX) Q2 2021 Earnings Call Transcript

·23-min read
CytomX Therapeutics, inc (CTMX) Q2 2021 Earnings Call Transcript
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

With me today are Dr. Sean McCarthy, CytomX's President, Chief Executive Officer and Chairman; Dr Amy Peterson, Chief Development Officer; and Carlos Campoy, Chief Financial Officer. Earlier today, we issued a press release that includes a summary of our second quarter 2021 financial results and highlights the important progress we made during the quarter.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting